Here we give the stock returns of the constituents in both our Canadian Cannabis LPs Portfolio (designated with a *) and the American Cannabis MSOs Portfolio in May, in descending order, and this week, the  Adj. EBITDA as a % of Net Revenue for each constituents - the higher the better - which is very helpful in determining the value of a company as compared to its peers and their latest quarterly financial reports (links provided):

1. Cronos* (CRON): down 11.9% in May (down 1.9% this week)
   • Adj. EBITDA of (42.2)% of Net Revenue
   • Cronos Q1 Financial Metrics Show Improvement
2. OrganiGram* (OGI): down 19.7% in May (down 6.0% this week)
   • Adj. EBITDA of (0.3)% of Net Revenue
   • Organigram Q2 Financial Metrics Mixed
3. Green Thumb (GTBIF): down 25.7% in May (up 1.0% this week)
   • Adj. EBITDA of 35.7% of Net Revenue
   • Net Profit of: 11.3% of Net Revenue
   • Green Thumb Q1 Financial Metrics Excel Across The Board
4. Curaleaf (CURLF): down 26.3% in May (down 1.3% this week)
   • Adj. EBITDA of 22.6% of Net Revenue
   • Curaleaf Reports 16% Reduction In Net Loss In Q1
5. Cresco Labs (CRLBF): down 26.3% in May (down 1.0% this week)
   • Adj. EBITDA of 28.8% of Net Revenue 
   • All Cresco Labs' QI Financial Metrics Down Except SG&A
6. Tilray* (TLRY): down 27.1% in May (down 2.7% this week)
   • Adj. EBITDA of 3.4% of Net Revenue
   • Tilray's Q3 Financials Disappoint
7. TerrAscend (TSNDF): down 29.4% in May (down 2.5% this week)
   • Adj. EBITDA of 20.1% of Net Revenue 
   • TerrAscend Reports 64% Reduction In Net Loss In Q1 Financial Report
8. Trulieve Cannabis (TCNNF): down 31.9% in May (down 6.1% this week)
   • Adj. EBITDA of 35.5% of Net Revenue
   • Trulieve Cannabis Q1 Financial Results Impressive
9. Aurora Cannabis* (ACB): down 32.9% in May (down 7.1% this week)
   • Adj. EBITDA of 3.4% of Net Revenue
   • Aurora Cannabis Q3 Financials Unimpressive
10. Verano (VRNOF): down 34.4% in May (up 1.2% this week)
    • Adj. EBITDA of 30.3% of Net Revenue
    • Verano Q1 Financial Metrics Down Across The BoardAyr Wellness (AYRWF): down 34.9% in May (down 2.6% this week)
      • Adj. EBITDA of 24.7% of Net Revenue
      • AYR Wellness' Q1 Financials Reveal 94% Reduction In Net Loss
11. Canopy Growth* (CGC): down 42.0% in May (down 6.0% this week)
    • Adj. EBITDA of (20.7)% of Net Revenue
    • Cannabis Growth Q4 Financials Unimpressive

Summary

The above 12 stocks are down 3.3%, on average, this week and are down 31.2%, on average, since the beginning of May but are up 24.0% YTD.

More By This Author:

Cannabis Growth Q4 Financials Unimpressive
What Is Adjusted EBITDA? Here's How The Largest Cannabis Companies Compare
These 17 AI Stocks Are The Sector's Most Undervalued